A detailed history of Freestone Capital Holdings, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 234,211 shares of PFE stock, worth $6.19 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
234,211
Previous 165,080 41.88%
Holding current value
$6.19 Million
Previous $4.62 Million 46.77%
% of portfolio
0.23%
Previous 0.17%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $1.91 Million - $2.17 Million
69,131 Added 41.88%
234,211 $6.78 Million
Q2 2024

Nov 22, 2024

BUY
$25.26 - $29.6 $568,299 - $665,940
22,498 Added 15.78%
165,080 $4.62 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $568,299 - $665,940
22,498 Added 15.78%
165,080 $4.62 Million
Q1 2024

Nov 22, 2024

SELL
$25.89 - $29.73 $2.37 Million - $2.72 Million
-91,629 Reduced 39.12%
142,582 $3.96 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $1.5 Million - $1.72 Million
57,927 Added 68.43%
142,582 $3.96 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $37,130 - $48,228
1,421 Added 1.71%
84,655 $2.44 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $136,125 - $159,117
-4,242 Reduced 4.85%
83,234 $2.76 Million
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $38,901 - $45,007
-1,077 Reduced 1.22%
87,476 $3.21 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $103,359 - $134,558
-2,624 Reduced 2.88%
88,553 $3.61 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $952,484 - $1.24 Million
-22,814 Reduced 20.01%
91,177 $4.67 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $459,042 - $560,375
-10,490 Reduced 8.43%
113,991 $4.99 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $1.06 Million - $1.26 Million
-22,777 Reduced 15.47%
124,481 $6.53 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $653,127 - $809,306
-14,276 Reduced 8.84%
147,258 $7.62 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $84,499 - $125,256
-2,045 Reduced 1.25%
161,534 $9.54 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $2.77 Million - $3.56 Million
-70,691 Reduced 30.18%
163,579 $7.04 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $87,799 - $99,462
-2,445 Reduced 1.03%
234,270 $9.17 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $695,352 - $784,218
20,763 Added 9.61%
236,715 $8.58 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $2.24 Million - $2.84 Million
66,796 Added 44.78%
215,952 $7.95 Billion
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $374,713 - $439,624
11,802 Added 8.59%
149,156 $5.19 Million
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $306,380 - $371,684
10,172 Added 8.0%
137,354 $4.49 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $899,828 - $1.29 Million
33,290 Added 35.46%
127,182 $4.15 Million
Q4 2019

Feb 04, 2020

BUY
$32.92 - $37.36 $992,241 - $1.13 Million
30,141 Added 47.28%
93,892 $3.68 Million
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $399,497 - $518,030
12,296 Added 23.9%
63,751 $2.29 Million
Q2 2019

Aug 05, 2019

SELL
$36.98 - $41.52 $7,580 - $8,511
-205 Reduced 0.4%
51,455 $2.23 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $188,737 - $207,359
5,033 Added 10.79%
51,660 $2.19 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $4.21 Million - $4.8 Million
-109,384 Reduced 70.11%
46,627 $2.04 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $357,764 - $433,945
-10,379 Reduced 6.24%
156,011 $6.88 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $220,570 - $235,150
6,688 Added 4.19%
166,390 $6.04 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $309,622 - $359,205
9,703 Added 6.47%
159,702 $5.67 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $270,137 - $286,625
8,122 Added 5.72%
149,999 $5.43 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $862,513 - $950,155
27,823 Added 24.39%
141,877 $5.07 Million
Q2 2017

Aug 15, 2017

BUY
N/A
114,054
114,054 $3.83 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.